Japan Patent Office grants 53rd patent for
product technology
COPPELL, Texas--(BUSINESS WIRE)--Aug. 9, 2012--
Mannatech,
Incorporated (NASDAQ: MTEX),
the leading innovator and provider of naturally sourced supplements
based on Real
Food Technology® solutions, announced today
that the Japan Patent Office has granted the company a patent for
technologies related to Ambrotose® complex. The patent is
officially titled “Compositions of Plant Carbohydrates as Dietary
Supplements.”
“At Mannatech, we’re equally devoted to both the innovation and
integrity of every nutritional product we formulate,” said Dr. Robert A.
Sinnott, CEO and Chief Science Officer of Mannatech. “We consider our
intellectual property to be one of our most valuable corporate assets.
Our Ambrotose technologies have consistently been granted patents from
governing bodies around the world. It’s a direct result of the
dedication and diligence exhibited by Mannatech’s scientists and serves
to further establish Mannatech as an industry leader in nutrition and
wellness.”
Mannatech currently holds more than 70 patents in 30 countries for its
health-related technologies. To date, 53 patents have been issued
worldwide for the technology related to Ambrotose complex.
Individuals interested in Mannatech’s products or in exploring its
business opportunity can learn more at Mannatech.com.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. Mannatech is dedicated
to its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing nutrition where it is needed most
around the world. Mannatech’s proprietary products are available through
independent sales Associates around the globe including the United
States, Canada, South Africa, Australia, New Zealand, Austria, Denmark,
Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan,
Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech
Republic, the Republic of Korea, Mexico and Namibia. For more
information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “believe,” “intend” or other similar words or the
negative of such terminology. Similarly, descriptions of Mannatech’s
objectives, strategies, plans, goals or targets contained herein are
also considered forward-looking statements. Mannatech believes this
release should be read in conjunction with all of its filings with the
United States Securities and Exchange Commission and cautions its
readers that these forward-looking statements are subject to certain
events, risks, uncertainties and other factors. Some of these factors
include, among others, Mannatech’s inability to attract and retain
Associates and Members, increases in competition, litigation, regulatory
changes and its planned growth into new international markets. Although
Mannatech believes that the expectations, statements and assumptions
reflected in these forward-looking statements are reasonable, it
cautions readers to always consider all of the risk factors and any
other cautionary statements carefully in evaluating each forward-looking
statement in this release, as well as those set forth in its latest
Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other
filings filed with the United States Securities and Exchange Commission,
including its current reports on Form 8-K. All of the forward-looking
statements contained herein speak only as of the date of this release.
Source: Mannatech, Incorporated
Mannatech, Incorporated
Brett Duncan, 972-471-7367
bduncan@mannatech.com